AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24517059 — intervention group
Group type: COMPARATOR
Intervention: Placebo control (10 g placebo each time, 3 times daily for 5 days)
Number of subjects: 136
Study 21499183 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time continuous glucose monitor with intravenous insulin infusion and rescue glucose (tight glycemic control arm)
Number of subjects: 311
Study 21499183 — intervention group
Group type: COMPARATOR
Intervention: Real-time continuous glucose monitor (standard care arm)
Number of subjects: 311
Study 21499183 — intervention group
Group type: COMPARATOR
Intervention: Real-time continuous glucose monitor alarms set at 60 mg/dL (3.3 mmol/L)
Number of subjects: 311
Study 21499183 — intervention group
Group type: COMPARATOR
Intervention: Real-time continuous glucose monitor alarms increased to 70 mg/dL (3.9 mmol/L)
Number of subjects: 311
Study 21499183 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall false hypoglycemia alarms
Number of subjects: 311
Study 19228385 — intervention group
Group type: EXPERIMENTAL
Intervention: Albendazole treatment every four months for 12 months
Number of subjects: 50
Study 19228385 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment every four months for 12 months
Number of subjects: 50
Study 19228385 — intervention group
Group type: EXPERIMENTAL
Intervention: Albendazole treatment at baseline
Number of subjects: 50
Study 19228385 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment at baseline
Number of subjects: 50
Study 17008814 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency, noncontact ultrasound therapy
Number of subjects: 23
Study 17008814 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (historical control)
Number of subjects: 23
Study 15194369 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoral
Number of subjects: 33
Study 15194369 — intervention group
Group type: COMPARATOR
Intervention: Prograf
Number of subjects: 33
Study 11071580 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmaceutical-grade collagen hydrolysate (PCH) 10 g daily
Number of subjects: 0
Study 11071580 — intervention group
Group type: COMPARATOR
Intervention: PCH
Number of subjects: 0
Study 11071580 — intervention group
Group type: COMPARATOR
Intervention: Calcitonin plus PCH
Number of subjects: 0
Study 9267682 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole 2.5 mg under fed conditions
Number of subjects: 12
Study 9267682 — intervention group
Group type: COMPARATOR
Intervention: Letrozole 2.5 mg under fasting conditions
Number of subjects: 12
Study 7892773 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% carbon dioxide challenge in situational or natural phenomena phobics
Number of subjects: 58
Study 7892773 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% carbon dioxide challenge in animal phobics
Number of subjects: 58
Study 7892773 — intervention group
Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 58
Study 3299441 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg of caffeine and mental arithmetic
Number of subjects: 18
Study 3299441 — intervention group
Group type: COMPARATOR
Intervention: Placebo and mental arithmetic
Number of subjects: 18
Study 3299441 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg of caffeine alone
Number of subjects: 18
Study 31599141 — intervention group
Group type: EXPERIMENTAL
Intervention: Cor-Knot titanium fastener
Number of subjects: 221
Study 31599141 — intervention group
Group type: COMPARATOR
Intervention: Hand-tied knots
Number of subjects: 221
Study 29086586 — intervention group
Group type: EXPERIMENTAL
Intervention: Diacutaneous fibrolysis
Number of subjects: 54
Study 28561421 — intervention group
Group type: EXPERIMENTAL
Intervention: Etofenamate patch
Number of subjects: 24
Study 28561421 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac patch
Number of subjects: 24
Study 25724656 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ghrelin (2 μg/kg, n=10)
Number of subjects: 20
Study 25724656 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=10)
Number of subjects: 20
Study 24051968 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic supplementation with Lactobacillus paracasei subsp. paracasei F-19
Number of subjects: 32
Study 24051968 — intervention group
Group type: COMPARATOR
Intervention: Standard medical treatment (Control)
Number of subjects: 32
Study 21360062 — intervention group
Group type: EXPERIMENTAL
Intervention: Value-added education
Number of subjects: 2621
Study 18335109 — intervention group
Group type: EXPERIMENTAL
Intervention: Amalgam
Number of subjects: 534
Study 18335109 — intervention group
Group type: COMPARATOR
Intervention: Resin composite (white fillings)
Number of subjects: 534
Study 16573795 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220
Study 14594787 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation (1000 mg elemental calcium daily for 12 months)
Number of subjects: 100
Study 14594787 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation
Number of subjects: 100
Study 14594787 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 100
Study 10980230 — intervention group
Group type: EXPERIMENTAL
Intervention: New index using 2-dimensional measurement of the reconstructed aortic arch
Number of subjects: 0
Study 8781012 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation techniques training at home
Number of subjects: 590
Study 8781012 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine blood pressure measurement by a health professional
Number of subjects: 590
Study 8781012 — intervention group
Group type: EXPERIMENTAL
Intervention: Reading self-learning packages
Number of subjects: 590
Study 8781012 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 590
Study 1395211 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (ACE-I) added to conventional therapy including digitalis, diuretics, or vasodilators
Number of subjects: 0
Study 6347233 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone 40 mg orally daily for 2 weeks
Number of subjects: 16
Study 6347233 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone
Number of subjects: 16
Study 6347233 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 30702960 — intervention group
Group type: EXPERIMENTAL
Intervention: Graphic Organizers (GO)
Number of subjects: 31
Study 29927746 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure and standard antenatal care
Number of subjects: 30
Study 29927746 — intervention group
Group type: COMPARATOR
Intervention: Standard antenatal care
Number of subjects: 30
Study 26900078 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg aripiprazole
Number of subjects: 0
Study 26900078 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg risperidone
Number of subjects: 0
Study 26900078 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 24859440 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultralow dose computerized tomography (sub mSv range)
Number of subjects: 48
Study 24859440 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultralow dose computerized tomography (filtered back projection)
Number of subjects: 48
Study 24859440 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultralow dose computerized tomography (adaptive statistical iterative reconstruction)
Number of subjects: 48
Study 24859440 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultralow dose computerized tomography (model based iterative reconstruction)
Number of subjects: 48
Study 24859440 — intervention group
Group type: COMPARATOR
Intervention: Ultralow dose computerized tomography
Number of subjects: 48
Study 21536208 — intervention group
Group type: EXPERIMENTAL
Intervention: Clearfil Protect Bond (Kuraray Medical, Okayama, Japan)
Number of subjects: 14
Study 21536208 — intervention group
Group type: COMPARATOR
Intervention: Transbond XT (3M Unitek, Monrovia, Calif)
Number of subjects: 14
Study 19427576 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone follow-up (Group B)
Number of subjects: 98
Study 19427576 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed follow-up (Group A)
Number of subjects: 98
Study 19427576 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group C)
Number of subjects: 98
Study 17001135 — intervention group
Group type: EXPERIMENTAL
Intervention: discharge summary curriculum
Number of subjects: 59
Study 17001135 — intervention group
Group type: EXPERIMENTAL
Intervention: curriculum plus individualized feedback
Number of subjects: 59
Study 17001135 — intervention group
Group type: COMPARATOR
Intervention: control group
Number of subjects: 59
Study 15188499 — intervention group
Group type: EXPERIMENTAL
Intervention: H pylori-positive NUD patients receiving 10-day triple eradication therapy
Number of subjects: 33
Study 15188499 — intervention group
Group type: EXPERIMENTAL
Intervention: NUD patients (overall)
Number of subjects: 33
Study 15188499 — intervention group
Group type: EXPERIMENTAL
Intervention: NUD patients before and after H pylori eradication
Number of subjects: 33
Study 15188499 — intervention group
Group type: COMPARATOR
Intervention: Asymptomatic controls
Number of subjects: 33
Study 11122299 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% saline
Number of subjects: 38
Study 11122299 — intervention group
Group type: COMPARATOR
Intervention: 3% saline
Number of subjects: 38
Study 11122299 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 38
Study 9491847 — intervention group
Group type: EXPERIMENTAL
Intervention: CHOP chemotherapy regimen
Number of subjects: 40
Study 8404251 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive, in-home family-based services
Number of subjects: 110
Study 8404251 — intervention group
Group type: COMPARATOR
Intervention: Routine out-of-home care services
Number of subjects: 110
Study 3527111 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine (n = 117)
Number of subjects: 224
Study 3527111 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine-antilymphocyte globulin (n = 107)
Number of subjects: 224
Study 4278962 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% lidocaine solution
Number of subjects: 199
Study 4278962 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% lidocaine solution
Number of subjects: 199
Study 4278962 — intervention group
Group type: COMPARATOR
Intervention: No topical lidocaine
Number of subjects: 199
Study 4278962 — intervention group
Group type: COMPARATOR
Intervention: Topical lidocaine (1% or 4%) vs No topical lidocaine
Number of subjects: 199
Study 30652920 — intervention group
Group type: EXPERIMENTAL
Intervention: Person-centred care plus standard cardiac care
Number of subjects: 199
Study 30652920 — intervention group
Group type: COMPARATOR
Intervention: Standard cardiac care
Number of subjects: 199
Study 28052214 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver nanoparticle-mixed sealant
Number of subjects: 40
Study 28052214 — intervention group
Group type: COMPARATOR
Intervention: Conventional pit and fissure sealant
Number of subjects: 40
Study 26011424 — intervention group
Group type: EXPERIMENTAL
Intervention: EPO (Eprex; 40,000 IU)
Number of subjects: 83
Study 26011424 — intervention group
Group type: COMPARATOR
Intervention: Saline (0.9% NaCl)
Number of subjects: 83
Study 24263115 — intervention group
Group type: EXPERIMENTAL
Intervention: Trandolapril
Number of subjects: 1731
Study 24263115 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1731
Study 21673577 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone support (TS) group
Number of subjects: 3424
Study 21673577 — intervention group
Group type: COMPARATOR
Intervention: Practice visit (PV) group
Number of subjects: 3424
Study 19616778 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 microg of oral misoprostol immediately after evacuation followed every 6 hours for 48 hours
Number of subjects: 160
Study 19616778 — intervention group
Group type: COMPARATOR
Intervention: No misoprostol
Number of subjects: 160
Study 16922750 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevel oriented posteriorly
Number of subjects: 70
Study 15763984 — intervention group
Group type: EXPERIMENTAL
Intervention: Integument reactions
Number of subjects: 84
Study 15763984 — intervention group
Group type: EXPERIMENTAL
Intervention: Hair loss
Number of subjects: 84
Study 15763984 — intervention group
Group type: EXPERIMENTAL
Intervention: Mucositis
Number of subjects: 84
Study 15763984 — intervention group
Group type: EXPERIMENTAL
Intervention: Rashes
Number of subjects: 84
Study 15763984 — intervention group
Group type: EXPERIMENTAL
Intervention: Palm and sole erythema
Number of subjects: 84
Study 15763984 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexural erythema with desquamation
Number of subjects: 84
Study 15763984 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug allergies
Number of subjects: 84
Study 15763984 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients' perception of skin problems
Number of subjects: 84
Study 15763984 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical or systemic skin treatment
Number of subjects: 84
Study 15763984 — intervention group
Group type: EXPERIMENTAL
Intervention: Compromised oncology treatment
Number of subjects: 84
Study 15763984 — intervention group
Group type: EXPERIMENTAL
Intervention: Extra nursing required
Number of subjects: 84
Study 15763984 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer hospital stay
Number of subjects: 84
Study 11369677 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with right anterior temporal lobe removal
Number of subjects: 2
Study 11369677 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with left anterior temporal lobe removal
Number of subjects: 2
Study 11369677 — intervention group
Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 2
Study 9431286 — intervention group
Group type: EXPERIMENTAL
Intervention: Stanford Nutrition Action Program
Number of subjects: 351
Study 9431286 — intervention group
Group type: COMPARATOR
Intervention: General nutrition curriculum
Number of subjects: 351
Study 8390044 — intervention group
Group type: EXPERIMENTAL
Intervention: BANA test incubated for 5 min at 35 degrees C
Number of subjects: 90
Study 8390044 — intervention group
Group type: EXPERIMENTAL
Intervention: BANA test incubated for 15 min at 35 degrees C
Number of subjects: 90
Study 8390044 — intervention group
Group type: EXPERIMENTAL
Intervention: BANA test incubated for 5 min at 45 degrees C
Number of subjects: 90
Study 8390044 — intervention group
Group type: EXPERIMENTAL
Intervention: BANA test incubated for 15 min at 45 degrees C
Number of subjects: 90
Study 8390044 — intervention group
Group type: EXPERIMENTAL
Intervention: BANA test incubated for 5 min at 55 degrees C
Number of subjects: 90
Study 8390044 — intervention group
Group type: EXPERIMENTAL
Intervention: BANA test incubated for 15 min at 55 degrees C
Number of subjects: 90
Study 3030109 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin/sulbactam
Number of subjects: 44
Study 3030109 — intervention group
Group type: COMPARATOR
Intervention: Metronidazole-gentamicin
Number of subjects: 44
Study 28304147 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dietary glycemic load (GL)
Number of subjects: 11159
Study 28304147 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dietary glycemic index (GI)
Number of subjects: 11159
Study 28304147 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher intake of sugar and sugar-sweetened beverages
Number of subjects: 11159
Study 28304147 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater intake of dietary fiber
Number of subjects: 11159
Study 28304147 — intervention group
Group type: EXPERIMENTAL
Intervention: Total carbohydrates or other carbohydrate-abundant foods
Number of subjects: 11159
Study 28028947 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-week cardiac rehabilitation program (interval training on a cycle ergometer)
Number of subjects: 90
Study 28028947 — intervention group
Group type: EXPERIMENTAL
Intervention: Four-week cardiac rehabilitation program (interval training on a cycle ergometer)
Number of subjects: 90
Study 28028947 — intervention group
Group type: COMPARATOR
Intervention: Breathing exercises, active free exercises of the peripheral joints and different muscle groups, relaxation exercises (Control Group)
Number of subjects: 90
Study 25552038 — intervention group
Group type: EXPERIMENTAL
Intervention: Ergoferon
Number of subjects: 162
Study 25552038 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 162
Study 23439910 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoor tanning facilities allowing children as young as 10 or 12 years old to use indoor-tanning devices.
Number of subjects: 243
Study 23439910 — intervention group
Group type: EXPERIMENTAL
Intervention: Claiming that indoor tanning would prevent future sunburns.
Number of subjects: 243
Study 23439910 — intervention group
Group type: EXPERIMENTAL
Intervention: Claiming that there were no risks associated with indoor tanning.
Number of subjects: 243
Study 23439910 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrasalon inconsistencies in allowable age of use and UVR exposure type and duration.
Number of subjects: 243
Study 19969525 — intervention group
Group type: EXPERIMENTAL
Intervention: Transbond Plus
Number of subjects: 126
Study 19969525 — intervention group
Group type: EXPERIMENTAL
Intervention: Beauty Ortho Bond
Number of subjects: 126
Study 19969525 — intervention group
Group type: EXPERIMENTAL
Intervention: Transbond XT
Number of subjects: 126
Study 19969525 — intervention group
Group type: COMPARATOR
Intervention: Control (24 hours storage)
Number of subjects: 126
Study 18784631 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical intervention (spinal fusion techniques: postero-lateral fusion, interbody fusion, flexible stabilization)
Number of subjects: 106
Study 18784631 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical intervention (complex procedures)
Number of subjects: 106
Study 18784631 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical intervention (smoking and unemployment status)
Number of subjects: 106
Study 18784631 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical intervention (litigation status)
Number of subjects: 106
Study 16485575 — intervention group
Group type: EXPERIMENTAL
Intervention: FDG SPECT in low LVEF group
Number of subjects: 47
Study 16485575 — intervention group
Group type: EXPERIMENTAL
Intervention: FDG SPECT in high LVEF group
Number of subjects: 47
Study 15570414 — intervention group
Group type: EXPERIMENTAL
Intervention: Biochemical markers of bone turnover (serum osteocalcin, bone-specific alkaline phosphatase, deoxypyridinoline, pyridinolines, type I collagen cross-linked C-terminal telopeptide, serum intact parathyroid hormone, 1,25 dihydroxy vitamin D)
Number of subjects: 2535
Study 15570414 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum calcium, phosphorus, PTH and 1,25(OH)2D levels
Number of subjects: 2535
Study 15570414 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic value of the markers
Number of subjects: 2535
Study 10669269 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous epidural infusion with bupivacaine 1 mg/ml and fentanyl 10 mg/ml (F10)
Number of subjects: 56
Study 10669269 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous epidural infusion with bupivacaine 1 mg/ml and fentanyl 5 microg/ml (F5)
Number of subjects: 56
Study 10669269 — intervention group
Group type: COMPARATOR
Intervention: Saline (S) plus i.v. PCA
Number of subjects: 56
Study 9086439 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal amphotericin-B, median dose of 2.8 (0.64-5.09) mg/kg body-weight for 13 (1-55) days
Number of subjects: 74
Study 9086439 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal amphotericin-B
Number of subjects: 74
Study 8444944 — intervention group
Group type: EXPERIMENTAL
Intervention: 6HR (isoniazid plus rifampicin for 6 months)
Number of subjects: 265
Study 8444944 — intervention group
Group type: EXPERIMENTAL
Intervention: 9HR (isoniazid plus rifampicin for 9 months)
Number of subjects: 265
Study 8444944 — intervention group
Group type: EXPERIMENTAL
Intervention: 9P/EH (isoniazid plus paraaminosalicylic acid or ethambutol for 9 months)
Number of subjects: 265
Study 8444944 — intervention group
Group type: EXPERIMENTAL
Intervention: 18P/EH (isoniazid plus paraaminosalicylic acid or ethambutol for 18 months)
Number of subjects: 265
Study 8444944 — intervention group
Group type: EXPERIMENTAL
Intervention: All series (combined)
Number of subjects: 265
Study 3896217 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline by wet nebulisation (5 mg, four times daily)
Number of subjects: 8
Study 3896217 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 29684136 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-mediated cognitive-behavioral exercise and dietary intervention (EX+D)
Number of subjects: 32
Study 29684136 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care (SC) control
Number of subjects: 32
Study 27835953 — intervention group
Group type: EXPERIMENTAL
Intervention: Experience-based website containing personal accounts of quitting smoking
Number of subjects: 87
Study 27835953 — intervention group
Group type: COMPARATOR
Intervention: Comparator website providing factual information
Number of subjects: 87
Study 24576866 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation (Ca-fortified beverage, 1 g·L)
Number of subjects: 33
Study 24576866 — intervention group
Group type: COMPARATOR
Intervention: Control beverage
Number of subjects: 33
Study 22182262 — intervention group
Group type: EXPERIMENTAL
Intervention: Seeking Safety (12 sessions)
Number of subjects: 353
Study 22182262 — intervention group
Group type: COMPARATOR
Intervention: Health education control condition
Number of subjects: 353
Study 19493579 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistent comorbid symptoms of depression and anxiety
Number of subjects: 2325
Study 19493579 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined presence of anxious and depressive symptoms
Number of subjects: 2325
Study 19493579 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistent depressive symptoms only
Number of subjects: 2325
Study 19493579 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistent anxious symptoms only
Number of subjects: 2325
Study 18760153 — intervention group
Group type: EXPERIMENTAL
Intervention: Grip strength (affected dominant side)
Number of subjects: 52
Study 18760153 — intervention group
Group type: EXPERIMENTAL
Intervention: Grip strength (affected nondominant side)
Number of subjects: 52
Study 18760153 — intervention group
Group type: EXPERIMENTAL
Intervention: Action Research Arm Test (ARAT) (affected dominant side)
Number of subjects: 52